Therefore, compared with N-NBs, LHRH-NBs theoretically have higher imaging intensity and longer imaging duration, and thus be a promising contrast agent in molecular imaging of ovarian cancer. This evidence concerns the gene GNRH1 and ovarian carcinoma.